PureTech Health PLC Asset Resilience Ratio

Latest as of March 2026: 4.64%

PureTech Health PLC asset resilience ratio. PureTech Health PLC (PRTC) has an Asset Resilience Ratio of 4.64% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PureTech Health PLC (PRTC) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$24.83 Million

Cash + Short-term Investments

Total Assets

$534.71 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of PureTech Health PLC (2012–2025)

Asset resilience ratio of PureTech Health PLC from 2012 to 2025. This chart shows how PureTech Health PLC's Asset Resilience Ratio has changed over time. Read PRTC total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down PureTech Health PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see PureTech Health PLC (PRTC) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$24.83 Million	4.64%
Total Liquid Assets	$24.83 Million	4.64%

Asset Resilience Insights

Limited Liquidity: PureTech Health PLC maintains only 4.64% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

PureTech Health PLC Industry Peers by Asset Resilience Ratio

Compare PureTech Health PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

PureTech Health PLC Asset Resilience Ratio by Year (2012–2025)

PureTech Health PLC asset resilience ratio by year from 2012 to 2025. The table below shows the annual Asset Resilience Ratio data for PureTech Health PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	4.64%	$24.83 Million	$534.71 Million	-9.74pp
2024-12-31	14.38%	$86.67 Million	$602.63 Million	-5.23pp
2023-12-31	19.61%	$136.06 Million	$693.97 Million	-8.89pp
2022-12-31	28.50%	$200.23 Million	$702.65 Million	+28.63pp
2021-12-31	-0.14%	$-1.28 Million	$946.01 Million	+0.04pp
2020-12-31	-0.17%	$-1.70 Million	$989.99 Million	-3.37pp
2019-12-31	3.20%	$30.09 Million	$941.18 Million	-27.10pp
2018-12-31	30.29%	$133.83 Million	$441.76 Million	-4.14pp
2017-12-31	34.43%	$117.03 Million	$339.85 Million	-39.01pp
2016-12-31	73.44%	$219.41 Million	$298.75 Million	+18.42pp
2015-12-31	55.02%	$179.78 Million	$326.75 Million	+54.51pp
2014-12-31	0.51%	$1.17 Million	$228.03 Million	-10.41pp
2013-12-31	10.92%	$1.83 Million	$16.77 Million	+4.79pp
2012-12-31	6.13%	$1.18 Million	$19.18 Million	--

pp = percentage points

About PureTech Health PLC

NASDAQ:PRTC USA Biotechnology

Market Cap

$423.06 Million

Market Cap Rank

#12809 Global

#3184 in USA

Share Price

$17.38

Change (1 day)

+4.51%

52-Week Range

$14.50 - $19.21

All Time High

$64.00